RESNATI, CHIARA

RESNATI, CHIARA  

Dipartimento di Scienze Biomediche e Cliniche  

Mostra records
Risultati 1 - 20 di 20 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Tenofovir plasma trough concentrations in people with HIV treated with doravirine versus other antiretroviral regimens 2021 Cattaneo D.Fusi M.Micheli V.Resnati C.Cossu M. V.Baldelli S.Antinori S. + Article (author) -
Effect of cobicistat on tenofovir disoproxil fumarate (TDF): what is true for TAF may also be true for TDF 2018 S. BaldelliC. MazzaliA. GiacomelliC. ResnatiE. ClementiM. Galli + Article (author) -
Dolutegravir and metformin : a clinically relevant or just a pharmacokinetic interaction? 2018 D. CattaneoC. Resnati + Article (author) -
Evaluation of the concentrations of psychotropic drugs in HIV-infected versus HIV-negative patients : Potential implications for clinical practice 2018 Resnati ChiaraGiacomelli AndreaClementi EmilioGalli Massimo + Article (author) -
IMPATTO DI COBICISTAT SU DURATA ETOLLERABILITA¿ DI REGIMI ANTIRETROVIRALICONTENENTI TENOFOVIR DIPROXIL FUMARATO 2018 RESNATI, CHIARA Doctoral Thesis -
The relevance of drug-drug interactions in clinical practice: the case of concomitant boosted protease inhibitors plus alpha-1 blocker administration 2018 C. ResnatiT. FormentiA. FossatiD. Cattaneo + Article (author) -
Correlation between inner retinal layer thickness and cognitive function in HIV: New insights from an exploratory study 2018 Invernizzi AAcquistapace ABochicchio SResnati CRusconi SLeta VStaurenghi GRiva A. + Article (author) -
Uptake of hepatitis C virus treatment in HIV/hepatitis C virus-coinfected patients across Europe in the era of direct-acting antivirals 2018 Resnati C + Article (author) -
Pharmacogenetics-based optimisation of atazanavir treatment : potential role of new genetic predictors 2017 C. ResnatiV. CozziD. CattaneoE.G.I. ClementiM. GalliA. Riva + Article (author) -
The impact of gastrectomy on the pharmacokinetics of atazanavir and tenofovir 2017 D. CattaneoC. ResnatiA. Riva + Article (author) -
Generics for the Treatment of Hepatitis C in Monoinfected and HIV-coinfected Patients: Pros and Cons 2017 Fossati AResnati CGalli M + Article (author) -
Effect of Legal Status on the Early Treatment Outcomes of Migrants Beginning Combined Antiretroviral Therapy at an Outpatient Clinic in Milan Italy 2017 C. ResnatiG. BozziS. AntinoriS. RusconiM. Galli + Article (author) -
Elvitegravir/cobicistat-associated toxic optical neuropathy in an HIV-infected patient: a call for caution? 2017 A. RivaA. InvernizziRESNATI, CHIARA + Article (author) -
Abacavir-induced liver toxicity 2016 M.D. PezzaniC. ResnatiV. Di CristoA. Riva + Article (author) -
Suspected pharmacokinetic interaction between raltegravir and the 3D regimen of ombitasvir, dasabuvir and paritaprevir/ritonavir in an HIV-HCV liver transplant recipient 2016 D. CattaneoN. CharbeC. ResnatiE. Clementi + Article (author) -
Comparison of the pharmacokinetics of raltegravir given at 2 doses of 400 mg by swallowing versus one dose of 800 mg by chewing in healthy volunteers : a randomized, open-label, 2-period, single-dose, crossover phase 1 study 2015 D. CattaneoM.V. CossuS. FucileA. RivaS. BaldelliC. ResnatiM. GalliE. ClementiA. Capetti + Article (author) -
Prolonged inductive effect of rifampicin on linezolid exposure 2015 F.R. SimonettiC. ResnatiN. CharbeE. ClementiD. Cattaneo + Article (author) -
Peripheral blood pre-erythroidal cells in HIV-1 infection 2015 M.S. TarkowskiC. ResnatiM. GalliA. Riva + Conference Object -
Analyses of Pre-erythroid cells in peripheral blood of patients with different progression of HIV infection 2015 M.S.TarkowskiC. ResnatiM. GalliA. Riva + Conference Object -
Changes in the incidence of severe thrombocytopenia and its predisposing conditions in HIV-infected patients since the introduction of highly active antiretroviral therapy 2014 M. FranzettiL. van Den BogaartC. ResnatiS. AntinoriM. Galli + Article (author) -